Tracking efforts to advance the mission and concept of “clinical research as a care option.”
The Evolution of CRAACO: Gains and Lessons Learned
Related Posts
Phase III MOVe-NOW Trial to Evaluate New Lagevrio Formulation Targeting High-Risk COVID-19 Patients
Credit: oz | stock.adobe.com Merck and Ridgeback Biotherapeutics have announced the initiation of the Phase III MOVe-NOW trial (NCT06667700), which will assess a new formulation […]
Bridging Innovation and Trust with Artificial Intelligence
In a recent video interview with Applied Clinical Trials, Michel van Harten, MD, CEO, myTomorrows, discussed the integration of artificial intelligence (AI) in clinical trials, […]
Clinical Strategies to Optimize Software as a Medical Device to treat Mental Health
Devin Ridgley, PhD, Director, Project Management, Medical Device and Diagnostics Research, ICON JoAnne Bronikowski, BSCS, RAC, Senior Manager, Regulatory Affairs, ICON Awareness of mental health […]